Application 021344
- Type
- NDA
- Sponsor
- ASTRAZENECA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FASLODEX | FULVESTRANT | INJECTABLE;INTRAMUSCULAR | 50MG/ML | Yes | Yes |
| 002 | FASLODEX | FULVESTRANT | SOLUTION;INTRAMUSCULAR | 125MG/2.5ML (50MG/ML) | Yes | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0310-0720 | FASLODEX | Fulvestrant | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0720 | FASLODEX | Fulvestrant | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0720 | FASLODEX | Fulvestrant | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0720 | FASLODEX | Fulvestrant | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0720 | FASLODEX | Fulvestrant | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0720 | FASLODEX | Fulvestrant | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0720 | FASLODEX | Fulvestrant | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0720 | FASLODEX | Fulvestrant | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0720 | FASLODEX | Fulvestrant | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-0720 | FASLODEX | Fulvestrant | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0310-7720 | Fulvestrant | Fulvestrant | AstraZeneca Pharmaceuticals LP | NDA AUTHORIZED GENERIC | Current |
| 0310-7720 | Fulvestrant | Fulvestrant | AstraZeneca Pharmaceuticals LP | NDA AUTHORIZED GENERIC | Current |
| 0310-7720 | Fulvestrant | Fulvestrant | AstraZeneca Pharmaceuticals LP | NDA AUTHORIZED GENERIC | Current |
| 0310-7720 | Fulvestrant | Fulvestrant | AstraZeneca Pharmaceuticals LP | NDA AUTHORIZED GENERIC | Current |
| 0310-7720 | Fulvestrant | Fulvestrant | AstraZeneca Pharmaceuticals LP | NDA AUTHORIZED GENERIC | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 65952 | SUPPL | 2021-01-21 |
| 65946 | SUPPL | 2021-01-21 |
| 64131 | SUPPL | 2020-07-30 |
| 64121 | SUPPL | 2020-07-29 |
| 62994 | SUPPL | 2020-05-14 |
| 62975 | SUPPL | 2020-05-13 |
| 61030 | SUPPL | 2019-11-22 |
| 61016 | SUPPL | 2019-11-22 |
| 60035 | SUPPL | 2019-09-23 |
| 60058 | SUPPL | 2019-09-20 |
| 60055 | SUPPL | 2019-09-20 |
| 58828 | SUPPL | 2019-05-22 |
| 58819 | SUPPL | 2019-05-21 |
| 57966 | SUPPL | 2019-03-12 |
| 57964 | SUPPL | 2019-03-12 |
| 54914 | SUPPL | 2018-07-19 |
| 54777 | SUPPL | 2018-07-06 |
| 52788 | SUPPL | 2018-03-01 |
| 52653 | SUPPL | 2018-02-15 |
| 50420 | SUPPL | 2017-11-15 |
| 50412 | SUPPL | 2017-11-15 |
| 49557 | SUPPL | 2017-08-28 |
| 49551 | SUPPL | 2017-08-28 |
| 46995 | SUPPL | 2017-01-27 |
| 45731 | SUPPL | 2016-10-31 |
| 15232 | SUPPL | 2016-07-13 |
| 5103 | SUPPL | 2016-07-13 |
| 36707 | SUPPL | 2016-05-23 |
| 5102 | SUPPL | 2016-05-20 |
| 15231 | SUPPL | 2016-03-04 |
| 5101 | SUPPL | 2016-03-04 |
| 36706 | SUPPL | 2016-03-03 |
| 5100 | SUPPL | 2016-03-03 |
| 27535 | SUPPL | 2012-11-13 |
| 5099 | SUPPL | 2012-11-13 |
| 36705 | SUPPL | 2012-11-08 |
| 15230 | SUPPL | 2012-11-08 |
| 15229 | SUPPL | 2012-07-25 |
| 27534 | SUPPL | 2012-07-17 |
| 27533 | SUPPL | 2011-09-29 |
| 5098 | SUPPL | 2011-09-29 |
| 36704 | SUPPL | 2011-09-26 |
| 36703 | SUPPL | 2011-09-26 |
| 15228 | SUPPL | 2011-05-23 |
| 27532 | SUPPL | 2011-05-19 |
| 51928 | SUPPL | 2011-02-01 |
| 51927 | SUPPL | 2011-02-01 |
| 51926 | SUPPL | 2011-02-01 |
| 51925 | SUPPL | 2011-02-01 |
| 51924 | SUPPL | 2011-02-01 |
| 51923 | SUPPL | 2011-02-01 |
| 5097 | SUPPL | 2010-09-13 |
| 5096 | SUPPL | 2010-09-13 |
| 15227 | SUPPL | 2010-09-10 |
| 15226 | SUPPL | 2010-09-10 |
| 36702 | SUPPL | 2005-08-08 |
| 27531 | SUPPL | 2005-08-08 |
| 36701 | SUPPL | 2004-01-15 |
| 5095 | SUPPL | 2004-01-14 |
| 42113 | ORIG | 2002-04-25 |
| 36700 | ORIG | 2002-04-25 |
| 27530 | ORIG | 2002-04-25 |